Real-time enrollment status for this pneumococcal disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:56 PM UTC
| NCT Number | NCT07660198 |
| Recruiting Status | Recruiting |
| Condition | Pneumococcal Disease |
| Phase | PHASE3 |
| Target Enrollment | 1,200 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 9, 2026 (Jul 9, 2026) |
As of August 27, 2026: Clinical trial NCT07660198 is currently recruiting participants. This phase3 study for pneumococcal disease is actively seeking new participants at 43 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07660198 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07660198 was last updated Jul 9, 2026 (July 9, 2026). HelloStudys verifies this status automatically.